Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy/Experiment 20/Signature 2

From BugSigDB
Needs review

Curated date: 2024/11/10

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Additional file 11: Figure S11

Description: Differentially abundant between the Naive group and HR (H-Isoniazid, R-Rifampin) treatment group.

Abundance in Group 1: decreased abundance in HR (H-Isoniazid, R-Rifampin)

NCBI Quality ControlLinks
Pseudobutyrivibrio
Butyricicoccus
Acetivibrio
Stomatobaculum
Christensenella
Sporobacter
Dorea
Robinsoniella
Eubacteriales Family XIII. Incertae Sedis
Clostridium
Oxobacter
Eisenbergiella
Tyzzerella
Arthrobacter
Intestinimonas
Guggenheimella
Pseudobacteroides
Turicibacter
Hydrogenoanaerobacterium
Ruminococcus
Acetatifactor
Roseburia
Eubacterium
Romboutsia
Pelotomaculum
Erysipelotrichaceae
Lactobacillus

Revision editor(s): KateRasheed